Literature DB >> 32804628

Accelerometer Measurements Indicate That Arm Movements of Children With Cerebral Palsy Do Not Increase After Constraint-Induced Movement Therapy (CIMT).

Brianna M Goodwin1, Emily K Sabelhaus2, Ying-Chun Pan3, Kristie F Bjornson4, Kelly L D Pham5, William O Walker6, Katherine M Steele7.   

Abstract

IMPORTANCE: Constraint-induced movement therapy (CIMT) is a common treatment for children with unilateral cerebral palsy (CP). Although clinic-based assessments have demonstrated improvements in arm function after CIMT, whether these changes are translated and sustained outside of a clinic setting remains unclear.
OBJECTIVE: Accelerometers were used to quantify arm movement for children with CP 1 wk before, during, and 4 wk or more after CIMT; measurements were compared with those from typically developing (TD) peers.
DESIGN: Observational.
SETTING: Tertiary hospital and community. PARTICIPANTS: Seven children with CP (5 boys, 2 girls; average [AVE] age ± standard deviation [SD] = 7.4 ± 1.2 yr) and 7 TD peers (2 boys, 5 girls; AVE age ± SD = 7.0 ± 2.3 yr). INTERVENTION: 30-hr CIMT protocol. OUTCOMES AND MEASURES: Use ratio, magnitude ratio, and bilateral magnitude were calculated from the accelerometer data. Clinical measures were administered before and after CIMT, and parent surveys assessed parent and child perceptions of wearing accelerometers.
RESULTS: During CIMT, the frequency and magnitude of paretic arm use among children with CP increased in the clinic and in daily life. After CIMT, although clinical scores showed sustained improvement, the children's accelerometry data reverted to baseline values. Children and parents in both cohorts had positive perceptions of accelerometer use. CONCLUSIONS AND RELEVANCE: The lack of sustained improvement in accelerometry metrics after CIMT suggests that therapy gains did not translate to increased movement outside the clinic. Additional therapy may be needed to help transfer gains outside the clinic. WHAT THIS ARTICLE ADDS: Accelerometer measurements were effective at monitoring arm movement outside of the clinic during CIMT and suggested that additional interventions may be needed after CIMT to sustain benefits.
Copyright © 2020 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32804628      PMCID: PMC7430726          DOI: 10.5014/ajot.2020.040246

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  25 in total

Review 1.  To constrain or not to constrain, and other stories of intensive upper extremity training for children with unilateral cerebral palsy.

Authors:  Andrew M Gordon
Journal:  Dev Med Child Neurol       Date:  2011-09       Impact factor: 5.449

2.  The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change.

Authors:  Lena Krumlinde-Sundholm; Marie Holmefur; Anders Kottorp; Ann-Christin Eliasson
Journal:  Dev Med Child Neurol       Date:  2007-04       Impact factor: 5.449

Review 3.  Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy: a Cochrane systematic review.

Authors:  Brian Hoare; Christine Imms; Leeanne Carey; Jason Wasiak
Journal:  Clin Rehabil       Date:  2007-08       Impact factor: 3.477

4.  Comparison of ActiGraph GT3X+ and Actical accelerometer data in 9-11-year-old Canadian children.

Authors:  M M Borghese; M S Tremblay; A G LeBlanc; G Leduc; C Boyer; J P Chaput
Journal:  J Sports Sci       Date:  2016-04-22       Impact factor: 3.337

5.  'Remind-to-move' treatment versus constraint-induced movement therapy for children with hemiplegic cerebral palsy: a randomized controlled trial.

Authors:  Vicky Anqin Dong; Kenneth N K Fong; Yun-Feng Chen; Stella S W Tseng; Louisa M S Wong
Journal:  Dev Med Child Neurol       Date:  2016-08-09       Impact factor: 5.449

6.  The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability.

Authors:  Ann-Christin Eliasson; Lena Krumlinde-Sundholm; Birgit Rösblad; Eva Beckung; Marianne Arner; Ann-Marie Ohrvall; Peter Rosenbaum
Journal:  Dev Med Child Neurol       Date:  2006-07       Impact factor: 5.449

7.  Assessment of arm activity using triaxial accelerometry in patients with a stroke.

Authors:  Sanne C van der Pas; Jeanine A Verbunt; Dorien E Breukelaar; Rachma van Woerden; Henk A Seelen
Journal:  Arch Phys Med Rehabil       Date:  2011-09       Impact factor: 3.966

8.  Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment.

Authors:  Edward Taub; Sharon Landesman Ramey; Stephanie DeLuca; Karen Echols
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124

9.  Everyday movement and use of the arms: Relationship in children with hemiparesis differs from adults.

Authors:  Brad Sokal; Gitendra Uswatte; Laura Vogtle; Ezekiel Byrom; Joydip Barman
Journal:  J Pediatr Rehabil Med       Date:  2015

10.  Efficacy of a hand-arm bimanual intensive therapy (HABIT) in children with hemiplegic cerebral palsy: a randomized control trial.

Authors:  Andrew M Gordon; Jennifer A Schneider; Ashley Chinnan; Jeanne R Charles
Journal:  Dev Med Child Neurol       Date:  2007-11       Impact factor: 5.449

View more
  2 in total

1.  3D Motion Capture May Detect Spatiotemporal Changes in Pre-Reaching Upper Extremity Movements with and without a Real-Time Constraint Condition in Infants with Perinatal Stroke and Cerebral Palsy: A Longitudinal Case Series.

Authors:  Julia Mazzarella; Mike McNally; Daniel Richie; Ajit M W Chaudhari; John A Buford; Xueliang Pan; Jill C Heathcock
Journal:  Sensors (Basel)       Date:  2020-12-19       Impact factor: 3.576

2.  Accelerometry-Based Metrics to Evaluate the Relative Use of the More Affected Arm during Daily Activities in Adults Living with Cerebral Palsy.

Authors:  Isabelle Poitras; Jade Clouâtre; Alexandre Campeau-Lecours; Catherine Mercier
Journal:  Sensors (Basel)       Date:  2022-01-28       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.